Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+13.69%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.64B
Cap. Flow
% of AUM
4.97%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| 1 |
Zscaler
ZS
|
+$279M |
| 2 |
Palantir
PLTR
|
+$257M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$229M |
| 4 |
Broadcom
AVGO
|
+$221M |
| 5 |
FirstEnergy
FE
|
+$184M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$361M |
| 2 |
Philip Morris
PM
|
+$297M |
| 3 |
Gilead Sciences
GILD
|
+$209M |
| 4 |
Entergy
ETR
|
+$209M |
| 5 |
Paychex
PAYX
|
+$199M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.27% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
MongoDB
MDB
$26.9B
| $7.56K | ﹤0.01% |
36
-9,995
| -100% | -$2.1M |
|
1852
Actinium Pharmaceuticals
ATNM
$49.9M
| $7.45K | ﹤0.01% |
5,321
-218
| -4% | -$305 |
|
|
GOGL
1853
DELISTED
Golden Ocean Group
GOGL
| $7.42K | ﹤0.01% |
1,013
-316
| -24% | -$2.31K |
|
1854
ACI Worldwide
ACIW
$5.29B
| $7.3K | ﹤0.01% |
159
-54
| -25% | -$2.48K |
|
1855
Zevra Therapeutics
ZVRA
$461M
| $7.26K | ﹤0.01% |
+824
| New | +$7.26K |
|
1856
LifeVantage
LFVN
$150M
| $7.19K | ﹤0.01% |
+550
| New | +$7.19K |
|
1857
Vera Bradley
VRA
$64.2M
| $7.16K | ﹤0.01% |
3,239
+2,759
| +575% | +$6.1K |
|
1858
Anterix
ATEX
$406M
| $7.11K | ﹤0.01% |
277
-58
| -17% | -$1.49K |
|
1859
VirTra
VTSI
$64.3M
| $6.85K | ﹤0.01% |
969
+567
| +141% | +$4.01K |
|
1860
CSG Systems International
CSGS
$1.88B
| $6.79K | ﹤0.01% |
104
-46
| -31% | -$3K |
|
1861
TransUnion
TRU
$18.3B
| $6.78K | ﹤0.01% |
77
-501
| -87% | -$44.1K |
|
1862
Merit Medical Systems
MMSI
$5.43B
| $6.64K | ﹤0.01% |
71
-239
| -77% | -$22.3K |
|
1863
Chesapeake Utilities
CPK
$2.93B
| $6.61K | ﹤0.01% |
55
-58
| -51% | -$6.97K |
|
1864
Fennec Pharmaceuticals
FENC
$257M
| $6.55K | ﹤0.01% |
+789
| New | +$6.55K |
|
1865
Perdoceo Education
PRDO
$2.17B
| $6.51K | ﹤0.01% |
199
-158
| -44% | -$5.17K |
|
1866
Eagle Bancorp Montana
EBMT
$139M
| $6.5K | ﹤0.01% |
+390
| New | +$6.5K |
|
1867
Patrick Industries
PATK
$3.72B
| $6.46K | ﹤0.01% |
70
-38
| -35% | -$3.51K |
|
1868
BARK
BARK
$151M
| $6.45K | ﹤0.01% |
7,331
+1,586
| +28% | +$1.4K |
|
1869
Nkarta
NKTX
$147M
| $6.32K | ﹤0.01% |
3,805
-1,561
| -29% | -$2.59K |
|
1870
Heidrick & Struggles
HSII
$1.04B
| $6.32K | ﹤0.01% |
138
+81
| +142% | +$3.71K |
|
1871
Electromed
ELMD
$222M
| $6.16K | ﹤0.01% |
280
+31
| +12% | +$682 |
|
1872
ProAssurance
PRA
$1.22B
| $6.12K | ﹤0.01% |
268
-68
| -20% | -$1.55K |
|
1873
UBS Group
UBS
$127B
| $6.09K | ﹤0.01% |
180
| – | – |
|
1874
iShares MSCI Japan Value ETF
EWJV
$493M
| $5.94K | ﹤0.01% |
171
| – | – |
|
1875
ClearPoint Neuro
CLPT
$311M
| $5.91K | ﹤0.01% |
+495
| New | +$5.91K |
|